Franklin India Technology Fund-Growth vs Nippon India Pharma Fund - Direct Plan Growth Plan - Bonus Option
Side-by-side comparison of NAV, returns, expense ratio and star rating.
TopFund Analysis
Franklin India Technology Fund-Growth appears stronger in terms of star rating with a 5-star rating compared to Nippon India Pharma Fund's 2-star rating, indicating a potentially better quality of management and performance. However, investors should note that while the Franklin fund has a higher star rating, it has lower returns over 1Y, 3Y, and 5Y periods compared to the Nippon fund, which offers higher returns but at a slightly lower expense ratio of 0.99%. For investors deciding between these two funds, the choice may hinge on whether they prioritize higher returns or a more highly rated fund.
Franklin India Technology Fund-Growth
Franklin Templeton Mutual Fund
★★★★★
Equity · Sectoral
Nippon India Pharma Fund - Direct Plan Growth Plan - Bonus Option
Nippon India Mutual Fund
★★★★★
Equity · Sectoral
| Metric | Franklin India Technol... | Nippon India Pharma Fu... |
|---|---|---|
| NAV | ₹544.36 | ₹646.81 |
| Star Rating | ★★★★★ | ★★ |
| Expense Ratio | 1.16% | 0.99% |
| AUM | ₹1,742 Cr | ₹9,166 Cr |
| 1M Return | +5.45% | +3.04% |
| 3M Return | -0.29% | +0.74% |
| 6M Return | +13.03% | +7.9% |
| 1Y Return | -5.8% | +10.92% |
| 3Y CAGR | +10.29% | +18.96% |
| 5Y CAGR | +7.22% | +14.59% |
| Risk Level | — | — |
| Fund Manager | Anand Radhakrishnan, Srikesh Nair, Varun Sharma | Sailesh Raj Bhan |